
PBMI gratefully acknowledges the support of Takeda
Pharmaceuticals North America (TPNA), Inc. for the provision of a grant to cover costs incurred in the production
of the Prescription Drug Benefit Cost and Plan Design Report.
TPNA has sponsored publication of the report since 2001. Takeda also
has underwritten the development of these supplemental electronic
resources to make research findings easy to access and use in benefit
planning. |